What’s the future of digital and data-driven operations look like for pharmaceutical manufacturers? How can we best understand the principles espoused in Pharma 4.0™ and apply them in practical, real-world applications?
Pharmaceutical manufacturers continue to look at how best to navigate and excel in a sea change of technological advancements. A central aspect of the digitization breakthrough described in the concept of Industry 4.0 across multiple different sectors is the adoption of advanced, data-driven technological solutions. The life sciences are no exception, as advanced concepts and tools have transformed the way the industry operates.
A key industry driver has been the implementation of these principles and technologies on fill-finish systems that address the full scope of drug product manufacturing operations. Products like ATMPs have shorter viability windows and require heightened quality-based processes, many of which have only been made possible by recent innovations.
In the October issue of Cleanroom Technology, AST CTO Steven Ng delves into the latest exciting Pharma 4.0 trends, including digital twin technology, and offers guidance on evaluating fill-finish operations for real-time solutions and digital optimization. Read the full article below.
